高级搜索
成远, 耿海云, 华海清. 阿帕替尼联合拓扑替康多线治疗铂类耐药复发性卵巢癌2例报告[J]. 肿瘤防治研究, 2018, 45(3): 188-190. DOI: 10.3971/j.issn.1000-8578.2018.17.0690
引用本文: 成远, 耿海云, 华海清. 阿帕替尼联合拓扑替康多线治疗铂类耐药复发性卵巢癌2例报告[J]. 肿瘤防治研究, 2018, 45(3): 188-190. DOI: 10.3971/j.issn.1000-8578.2018.17.0690
CHENG Yuan, GENG Haiyuan, HUA Haiqing. Multi-line Treatment Combined Apatinib with Toptecan for Platinum-resistant Recurrent Ovarian Cancer: Two Cases Report[J]. Cancer Research on Prevention and Treatment, 2018, 45(3): 188-190. DOI: 10.3971/j.issn.1000-8578.2018.17.0690
Citation: CHENG Yuan, GENG Haiyuan, HUA Haiqing. Multi-line Treatment Combined Apatinib with Toptecan for Platinum-resistant Recurrent Ovarian Cancer: Two Cases Report[J]. Cancer Research on Prevention and Treatment, 2018, 45(3): 188-190. DOI: 10.3971/j.issn.1000-8578.2018.17.0690

阿帕替尼联合拓扑替康多线治疗铂类耐药复发性卵巢癌2例报告

Multi-line Treatment Combined Apatinib with Toptecan for Platinum-resistant Recurrent Ovarian Cancer: Two Cases Report

/

返回文章
返回